Attending physician, MD, graduated from Shanghai Jiao Tong University School of Medicine, visiting scholar at Institut Curie, Paris, France from 2016 to 2017. Nominated for "Top Ten Outstanding Youth of Ruijin Hospital," and leader of "Shanghai Jiao Tong University Youth League Pioneer Post." Has been engaged in tumor radiotherapy and chemotherapy for over ten years at Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. Mainly focuses on comprehensive radiotherapy and chemotherapy treatment centered on gynecological tumor radiotherapy; adhering to the concept of precision treatment, relying on our hospital being one of only two units in Shanghai performing CT three-dimensional positioning brachytherapy, with treatment technology at a leading domestic level and comparable to international standardized treatment levels. In recent years, has completed over a hundred cases of three-dimensional positioning brachytherapy, including intracavitary brachytherapy for gynecological tumors, adjuvant and palliative intracavitary brachytherapy for low rectal and anal canal cancer, etc. In recent years, has been committed to research on tumor radiotherapy sensitivity, publishing over ten original articles, with the highest single SCI impact factor exceeding 5. Has successively received funding from the "Shanghai Jiao Tong University School of Medicine Doctoral Innovation Fund," "Shanghai University Young Teacher Training Program," "Shanghai Young Physician Training Program," and "National Natural Science Foundation" projects. During the visiting scholar period at Institut Curie, completed 2 studies as first author and 4 collaborative studies, all accepted by internationally authoritative journals in tumor radiotherapy.